SHILPAMED Q1 FY27 results at a glance
SHILPA MEDICARE LTD Q1 FY27 key results metrics| Quarter | Q1 FY27 |
|---|
| Quarter ended | 30 Jun 2026 |
|---|
| Revenue | ₹466 cr |
|---|
| Revenue YoY | +44.9% |
|---|
| Operating profit | ₹101 cr |
|---|
| Operating margin | 21.7% |
|---|
| Net profit | ₹101 cr |
|---|
| Net profit YoY | +115.2% |
|---|
| Net profit QoQ | -6.4% |
|---|
| Net margin | 21.7% |
|---|
| Basic EPS | ₹5.16 |
|---|
| TTM revenue | ₹1,682 cr |
|---|
| TTM net profit | ₹297 cr |
|---|
| TTM net margin | 17.7% |
|---|
SHILPAMED Q1 FY27 results: what the numbers say
SHILPA MEDICARE LTD (SHILPAMED) has reported its Q1 FY27 results for the quarter ended 2026-06-30. The company posted revenue of ₹466 cr and a net profit of ₹101 cr, translating into earnings per share of ₹5.16.
Compared with the same quarter a year earlier, revenue grew strongly by +44.9% and net profit grew sharply by +115.2%. Profit rising faster than revenue points to better cost control or operating leverage flowing through the P&L.
Operating profit for the quarter stood at ₹101 cr, an operating margin of 21.7% versus 19.5% a year ago — a gain of 2.2 percentage points.
SHILPAMED quarter-wise results table
Net profit
₹101 cr
+115.2% YoY
Operating profit
₹101 cr
+61.1% YoY
SHILPA MEDICARE LTD (SHILPAMED) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|
| Q1 FY272026-06-30 | ₹466 cr | ₹101 cr | ₹101 cr | 21.7% | 21.7% | ₹5.16 | +115.2% | -6.4% |
| Q4 FY262026-03-31 | ₹437 cr | ₹106 cr | ₹108 cr | 24.3% | 24.7% | ₹5.51 | — | +141.8% |
| Q3 FY262025-12-31 | ₹410 cr | ₹83.94 cr | ₹44.58 cr | 20.5% | 10.9% | ₹2.36 | — | +1.2% |
| Q2 FY262025-09-30 | ₹370 cr | ₹78.46 cr | ₹44.07 cr | 21.2% | 11.9% | ₹1.13 | — | -6.0% |
| Q1 FY262025-06-30 | ₹321 cr | ₹62.72 cr | ₹46.88 cr | 19.5% | 14.6% | ₹2.40 | — | — |
| TTM (last 4 quarters) | ₹1,682 cr | ₹370 cr | ₹297 cr | 22.0% | 17.7% | ₹14.15 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
SHILPAMED quarterly income statement
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
SHILPA MEDICARE LTD quarterly income statement| Particulars | Q1 FY272026-06-30 | Q4 FY262026-03-31 | Q3 FY262025-12-31 | Q2 FY262025-09-30 | Q1 FY262025-06-30 |
|---|
| Revenue / Sales | ₹466 cr | ₹437 cr | ₹410 cr | ₹370 cr | ₹321 cr |
|---|
| Total expenses | ₹365 cr | ₹331 cr | ₹326 cr | ₹292 cr | ₹259 cr |
|---|
| Gross profit | ₹331 cr | ₹295 cr | ₹276 cr | ₹264 cr | ₹242 cr |
|---|
| Operating profit (EBIT) | ₹101 cr | ₹106 cr | ₹83.94 cr | ₹78.46 cr | ₹62.72 cr |
|---|
| Operating margin | 21.7% | 24.3% | 20.5% | 21.2% | 19.5% |
|---|
| Interest cost | ₹12.1 cr | ₹30.62 cr | ₹10.68 cr | ₹15.67 cr | ₹18.78 cr |
|---|
| Profit before tax | ₹98.06 cr | ₹120 cr | ₹60.85 cr | ₹64.43 cr | ₹49.58 cr |
|---|
| Tax expense | -₹2.83 cr | ₹12.66 cr | ₹16.27 cr | ₹20.36 cr | ₹2.69 cr |
|---|
| Effective tax rate | -2.9% | 10.5% | 26.7% | 31.6% | 5.4% |
|---|
| Net profit (PAT) | ₹101 cr | ₹108 cr | ₹44.58 cr | ₹44.07 cr | ₹46.88 cr |
|---|
| Net profit margin | 21.7% | 24.7% | 10.9% | 11.9% | 14.6% |
|---|
| Basic EPS | ₹5.16 | ₹5.51 | ₹2.36 | ₹1.13 | ₹2.40 |
|---|
| Diluted EPS | ₹5.16 | ₹5.51 | ₹2.36 | ₹1.13 | ₹2.40 |
|---|
SHILPAMED results growth — YoY and QoQ
Quarterly growth rates, year on year and quarter on quarter| Growth | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 |
|---|
| Revenue YoY | +44.9% | — | — | — | — |
|---|
| Revenue QoQ | +6.6% | +6.7% | +10.7% | +15.1% | — |
|---|
| Operating profit YoY | +61.1% | — | — | — | — |
|---|
| Operating profit QoQ | -4.7% | +26.3% | +7.0% | +25.1% | — |
|---|
| Net profit YoY | +115.2% | — | — | — | — |
|---|
| Net profit QoQ | -6.4% | +141.8% | +1.2% | -6.0% | — |
|---|
| EPS YoY | +115.0% | — | — | — | — |
|---|
| EPS QoQ | -6.4% | +133.5% | +109.8% | -53.1% | — |
|---|
SHILPAMED annual results history
Full-year performance for SHILPA MEDICARE LTD, useful for reading each quarter in context.
SHILPA MEDICARE LTD annual income statement| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|
| Revenue / Sales | ₹1,538 cr | ₹1,285 cr | ₹1,152 cr | ₹1,043 cr |
|---|
| Total expenses | ₹1,268 cr | ₹1,085 cr | ₹1,017 cr | ₹1,048 cr |
|---|
| Gross profit | ₹1,078 cr | ₹874 cr | ₹743 cr | ₹627 cr |
|---|
| Operating profit (EBIT) | ₹270 cr | ₹200 cr | ₹134 cr | -₹4.6 cr |
|---|
| Operating margin | 17.6% | 15.5% | 11.6% | -0.4% |
|---|
| Interest cost | ₹46.6 cr | ₹75.54 cr | ₹83.71 cr | ₹56.25 cr |
|---|
| Profit before tax | ₹295 cr | ₹122 cr | ₹54.34 cr | -₹38.28 cr |
|---|
| Tax expense | ₹51.99 cr | ₹44.04 cr | ₹22.39 cr | -₹7.31 cr |
|---|
| Effective tax rate | 17.6% | 36.0% | 41.2% | 19.1% |
|---|
| Net profit (PAT) | ₹243 cr | ₹78.29 cr | ₹31.87 cr | -₹32.53 cr |
|---|
| Net profit margin | 15.8% | 6.1% | 2.8% | -3.1% |
|---|
| Basic EPS | ₹12.44 | ₹4.02 | ₹1.83 | ₹-1.88 |
|---|
| Diluted EPS | ₹12.44 | ₹4.02 | ₹1.83 | ₹-1.88 |
|---|
Revenue trend and demand read-through
Topline for Q1 FY27 came in at ₹466 cr against ₹321 cr in Q1 FY26, and ₹437 cr in the preceding Q4 FY26 quarter.
On a sequential basis revenue grew +6.6%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹365 cr, or 78.3% of revenue, with operating profit grew +61.1% year on year.
Margins, tax and profitability
Net profit of ₹101 cr works out to a net margin of 21.7% compared with 14.6% in the year-ago quarter. Margin expansion of this kind usually reflects a better product or service mix, softer input costs, or tighter overheads.
Below the operating line, SHILPA MEDICARE LTD reported profit before tax of ₹98.06 cr, a tax charge of -₹2.83 cr (effective rate -2.9%), interest cost of ₹12.1 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from ₹108 cr in Q4 FY26 to ₹101 cr in Q1 FY27, a change of -6.4%.
Trailing twelve months and annual context
Across the trailing four quarters SHILPA MEDICARE LTD has generated revenue of ₹1,682 cr and net profit of ₹297 cr, a trailing net margin of 17.7%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹1,538 cr with net profit of ₹243 cr and EPS of ₹12.44, versus the prior year where revenue grew +19.7% and profit grew +210.8%.
What to watch in the next SHILPAMED quarter
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A sustained run of year-on-year profit growth is what usually drives a re-rating rather than any single quarter.
SHILPA MEDICARE LTD has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.
All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
SHILPAMED results coverage
No results report published for SHILPAMED yet — our desk covers each quarter within minutes of the filing.
SHILPAMED quarterly results FAQs
What were SHILPA MEDICARE LTD (SHILPAMED) Q1 FY27 results?
In Q1 FY27 (quarter ended 30 Jun 2026), SHILPA MEDICARE LTD reported revenue of ₹466 cr and net profit of ₹101 cr, a change of +115.2% year on year on +44.9% revenue growth. EPS stood at ₹5.16.
What is SHILPAMED profit margin in Q1 FY27?
SHILPA MEDICARE LTD posted a net profit margin of 21.7% and an operating margin of 21.7% in Q1 FY27. On a trailing twelve-month basis, revenue is ₹1,682 cr and net profit ₹297 cr.
Did SHILPAMED results beat the previous quarter?
SHILPA MEDICARE LTD net profit changed -6.4% quarter on quarter, from ₹108 cr in Q4 FY26 to ₹101 cr in Q1 FY27.
When are SHILPA MEDICARE LTD (SHILPAMED) quarterly results?
SHILPA MEDICARE LTD has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Where can I see SHILPAMED latest quarterly results?
Results coverage for SHILPAMED will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the SHILPAMED stock page.
What is SHILPA MEDICARE LTD annual revenue and profit?
For FY26, SHILPA MEDICARE LTD reported full-year revenue of ₹1,538 cr and net profit of ₹243 cr, with EPS of ₹12.44.
How many quarterly results has SHILPAMED declared recently?
Past results dates for SHILPAMED will be listed here from the exchange calendar.
Results dates sourced from the exchange board-meeting calendar; reported figures from company filings, last refreshed 11 Sept 2026. For information only, not investment advice.
